Drug maker Lupin has posted a net profit of Rs 115.62 crore for the second quarter ended September 30, a 52.85 per cent growth over the Rs 75.64 crore in the corresponding quarter last year, a company release to Bombay Stock Exchange said.
The total consolidated income rose to Rs 934.31 crore in the quarter under review, a 38.62 per cent rise from Rs 673.99 crore in the same period last fiscal.
Shares of the company were trading at Rs 621, down 2.34 per cent in the morning trade.
